You are here: Industry Insights > SARS-CoV-2

News List

Rapid COVID-19 Genome Sequencing Aids Outbreak Investigations americanpharmaceuticalreview
May 08, 2020
Thermo Fisher Scientific has optimized its Ion AmpliSeq SARS-CoV-2 Research Panel for the Ion Torrent Genexus System.
Thermo Fisher Launches SARS-CoV-2 GlobalAccess Sequencing Program contractpharma
May 08, 2020
Provides 50 units of the Genexus System at a subsidized price to support global collaborative COVID-19 research.
JEDI launches billion molecules agains COVID19 challenge pharmatimes
May 06, 2020
The Joint European Disruptive Initiative (JEDI) has launched a new initiative to bring together the world's scientists for a united attack against the novel coronavirus pandemic.
Eli Lilly, Junshi collaborate to develop antibody therapies for Covid-19 disease pharmaceutical-business-review
May 05, 2020
Eli Lilly has collaborated with Junshi Biosciences for the development of therapeutic antibodies to treat and prevent Covid-19, the disease resulted due to the SARS-CoV-2 novel coronavirus.
Researchers identify antibody with activity against SARS-CoV-2 in lab pharmaceutical-technology
May 05, 2020
Researchers at Utrecht University and Erasmus Medical Center in the Netherlands, in alliance with China-based firm Harbour BioMed, have identified a fully human monoclonal antibody with activity against the novel coronavirus, SARS-CoV-2.
Convalescent Plasma Trial Begins as Potential Treatment for COVID-19 americanpharmaceuticalreview
May 05, 2020
Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have launched a new clinical trial to study if convalescent plasma, taken from people who have recovered from COVID-19, is effective in treating the disease.
Eiger Announces First COVID-19 Patients Dosed with Peginterferon Lambda americanpharmaceuticalreview
May 05, 2020
Eiger BioPharmaceuticals announced the first patients have been dosed in a Phase 2 study of peginterferon lambda (Lambda) in outpatients with mild COVID-19 at the Stanford University School of Medicine.
ProteoGenix Announces a COVID-19 Antibody Library americanpharmaceuticalreview
May 04, 2020
ProteoGenix has announced the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2.
Leinco, Vanderbilt University Medical Center to Deliver Rapid COVID-19 Test americanpharmaceuticalreview
April 30, 2020
Leinco Technologies announced an agreement with Vanderbilt University Medical Center (VUMC) to scale up production of its most promising antibodies for development of a rapid, point of care COVID-19 diagnostic test.
Spanish Medicines Agency Authorizes Aplidin, APLICOV-PC Trial for COVID-19 americanpharmaceuticalreview
April 30, 2020
PharmaMar has announced the start of the APLICOV-PC clinical trial with Aplidin® (plitidepsin), for the treatment of patients with COVID-19, which has been authorized by the Spanish Medicines and Healthcare Products Agency (AEMPS).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page